全球视网膜植入物市场 – 行业趋势及 2029 年预测

市场分析和规模

视网膜植入物是一种用于替代失明患者眼内光传导的装置。近几年来，视网膜假体取得了长足进步。因此，人们开发出了各种独特的手术方法。先进的图像处理算法和数据传输系统的采用，以及纳米制造和导电聚合技术的开发，正在推动北美和欧洲发达国家对视网膜植入物的需求。

Data Bridge Market Research 分析认为，2021 年视网膜植入物市场规模为 310 亿美元，到 2029 年将飙升至 724.8 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 11.20%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分

市场定义

Retinal implants are biomedical microchips that help people who have lost their eyesight due to degenerative eye illnesses including retinitis pigmentosa or age-related macular degeneration. These disorders cause photoreceptor cells in the retina of human eyes to slowly devolve, resulting in gradual vision loss. In most cases, however, some of the inner retinal neurons that transmit signals from photoreceptors to the brain are preserved. Retinal implants, which are essentially microchips holding an array of light-sensitive diodes capable of converting incident light into electrical signals, can help patients regain some vision.

Retinal Implant Market Dynamics

Drivers

• Approved devices for restoring vision

With the use of electrodes, camera chips, lenses, software, and other instruments, currently authorised devices can restore vision. Furthermore, the Argus II small implantable telescope is simple to operate and allows patients to go about their regular activities with ease. Furthermore, these devices can be utilised for a long time, obviating the necessity for a second surgery. Therefore, the ability of innovative implantable devices to restore vision is expected to propel the market growth.

• Growing geriatric population and rising disposable income

Over the forecast period, the retinal implant market is expected to benefit from an increasing geriatric population and increased disposable income in developing economies such as Japan, China, and India. Furthermore, rising healthcare spending by governments and the private sector and endeavors by leading market players to operate in underserved regions are expected to drive market expansion.

• Use of electrical stimulation

Electrical stimulation of these residual retinal neurons using retinal implants, which are essentially microchips containing an array of light-sensitive diodes capable of translating incident light into electrical signals, can help patients regain some vision and drives the market growth.

Opportunities

AMD is the cause of blindness in about 5.0 percent of the world's blind people, according to the International Agency for the Prevention of Blindness (IAPB). Furthermore, according to the same source, around 196 million people may be affected by AMD by 2020, with the figure anticipated to rise to around 288 million by 2040. As a result, the worldwide retinal implants market is likely to be driven by the presence of a high patient population over the forecast period.

Restraints/Challenges

The important hurdles facing the worldwide retinal implants market include complex surgery, differences in people's biological responses to foreign items being placed within their bodies, and high procedure costs. Because of the complexity of implant surgeries, complete training in technology and methodology and proper patient selection are critical components in the widespread adoption of retinal implants. Demand for retinal implants is being hampered by a scarcity of educated experts in some areas.

This retinal implant market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the retinal implant market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Retinal Implant Market

COVID-19, a highly contagious respiratory virus, presents unique challenges to ophthalmology practice as a high-volume, office-based specialty. Our ophthalmology clinic implemented many operational adjustments in response to the COVID-19 epidemic to improve patient and provider safety while preserving critical clinical activities. The goal of this study was to see how pandemic-era metrics affected retina clinic performance and patient satisfaction and estimate future clinic flow to anticipate operational performance under growing patient and provider numbers.

Global Retinal Implant Market Scope

The retinal implant market is segmented on the basis of device type, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Device Type

• Retina implant alpha AMS
• Implantable miniature telescope
• Argus II
• Others

End-user

• Hospitals
• Ambulatory Surgical Centers
• Other

Retinal implant Market Regional Analysis/Insights

The retinal implant market is analysed and market size insights and trends are provided by country, device type, and end-user as referenced above.

The countries covered in the retinal implant market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to generate the highest revenue in the global retinal implant market. Over the forecast period, the high frequency of degenerative disorders and technological developments may fuel growth in the North American retinal implants market.

Asia-Pacific, the market for retinal implants is expected to hold the highest market share over the forecast period. The market is expected to benefit from an increase in the senior population and disposable income. Furthermore, rising government and private sector healthcare spending and different endeavours by key market players to expand into untapped regions are expected to drive regional market expansion.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The retinal implant market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for retinal implant market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the retinal implant market. The data is available for historic period 2010-2020.

Competitive Landscape and Retinal Implant Market Share Analysis

视网膜植入物市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对视网膜植入物市场的关注有关。

视网膜植入物市场的一些主要参与者包括：

• 雅培（美国）
• 仿生视觉技术公司（美国）
• Drägerwerk AG & Co. KGaA（德国）
• Labtician Ophthalmics, Inc. (加拿大)
• Nano Retina（以色列）
• Koninklijke Philips NV（荷兰）
• Pixium Vision（法国）
• Retina Implant AG（德国）
• Second Sight（美国）
• VisionCare, Inc.（美国）
• Visus Technology, Inc.（美国）
•  波士顿视网膜植入项目（美国）
• IMI Intelligent Medical Implants AG（德国）
• Cicor Management AG（瑞士）

SKU-68649